as on October 22, 2025 at 1:29 am IST
Day's Low
Day's High
0.73%
Downside
0.56%
Upside
52 Week's Low
52 Week's High
24.11%
Downside
20.81%
Upside
Check Biontech Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$26.0B
EPS (TTM)
-4.0147
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.43%
PE Ratio (TTM)
-40.18
Industry PE ratio
19.200384615384614
PEG Ratio
0.0449
EBITDA
-493.7M
Revenue (TTM)
2.9B
Profit Margin
-11.98%
Return On Equity TTM
1353700.00%
Track how Biontech Se P/E has moved over time to understand its valuation trends.
Biontech Se in the last 5 years
Lowest (-69.14x)
June 30, 2025
Today (-40.18x)
October 22, 2025
Industry (19.20x)
October 22, 2025
Highest (26.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -40.18x
Compare market cap, revenue, PE, and other key metrics of Biontech Se with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $26.0B | 23.77% | -40.18 | -11.98% | |
BUY | $34.9B | 342.12% | -16.34 | -259.82% | |
BUY | $64.4B | 252.94% | -505.15 | -12.96% | |
BUY | $107.5B | 102.91% | 29.68 | 31.86% | |
BUY | $61.3B | 0.63% | 14.58 | 31.37% |
The Biontech Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biontech Se investment value today
Current value as on today
₹1,01,308
Returns
₹1,308
(+1.31%)
Returns from Biontech Se Stock
Dollar Returns*
₹4,808 (+4.81%)
Based on 24 analysts
54.17%
Buy
37.50%
Hold
8.33%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Biontech Se. Average target price of $134.98
Get share price movements and forecasts by analysts on Biontech Se.
What analysts predicted
20.73%UPSIDE
Target Price
$134.98
Current Price
$107
Analyzed by
24 Analysts
Target
$134.98
Biontech Se target price $134.98, a slight upside of 20.73% compared to current price of $107. According to 24 analysts rating.
Search interest for Biontech Se Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 October
Fri, 12:36 PM
-EU boosts Rwanda's vaccine production with €95 million, supporting BioNTech's first African manufacturing site.
Fri, 05:41 PM
-Morgan Stanley lowers BioNTech price target to $131 but maintains Overweight rating ahead of Q3 earnings.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
BioNTech SE has shown an improvement in its net profit over the last two quarters. The net profit increased from -$415.8 million to -$386.6 million, reflecting an average increase of 7.6% per quarter.
Revenue Rich
Biontech SE has shown strong performance in its revenue over the last two quarters. Revenue increased from $182.8 million to $260.8 million, indicating an average growth of 29.9% per quarter.
Price Rise
In the last 1 month, BNTX stock has moved up by 8.3%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 63.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 157.1%
Organisation | Biontech Se |
Headquarters | An der Goldgrube 12, Mainz, Germany, 55131 |
Industry | Health Technology |
CEO | Dr. Ugur Sahin M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board |
Dr. Sierk Poetting Ph.D. | MD, COO & Member of Management Board |
Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal & Business Officer and Member of the Management Board |
Mr. Ramon Zapata-Gomez | CFO & Member of Management Board |
Ms. Lisa Birringer | Senior Vice President of Global Financial Reporting & Accounting |
Ms. Beate Berns | Senior Vice President of Global Human Resources |
Dr. Oliver Henning Ph.D. | Senior Vice President of Operations |
Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board |
Ms. Annemarie Hanekamp | Chief Commercial Officer & Member of Management Board |
Dr. Sebastian Kreiter M.D. | Senior Vice President of Immunotherapy & Preclinical Research |
Biontech Se share price today is $107 as on at the close of the market. Biontech Se share today touched a day high of $107.6 and a low of $106.22.
Biontech Se share touched a 52 week high of $129.27 on and a 52 week low of $81.2 on . Biontech Se stock price today i.e. is closed at $107,which is 17.23% down from its 52 week high and 31.77% up from its 52 week low.
Biontech Se market capitalisation is $0.03T as on .
Indian investors can start investing in Biontech Se (BNTX) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Biontech Se stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biontech Se share’s latest price of $107 as on October 22, 2025 at 1:29 am IST, you will get 0.0935 shares of Biontech Se. Learn more about
fractional shares .
Biontech Se stock has given 23.77% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?